AU8559398A - Remedies for cerebral central lesions with the use of neurotrophic factors - Google Patents

Remedies for cerebral central lesions with the use of neurotrophic factors

Info

Publication number
AU8559398A
AU8559398A AU85593/98A AU8559398A AU8559398A AU 8559398 A AU8559398 A AU 8559398A AU 85593/98 A AU85593/98 A AU 85593/98A AU 8559398 A AU8559398 A AU 8559398A AU 8559398 A AU8559398 A AU 8559398A
Authority
AU
Australia
Prior art keywords
remedies
neurotrophic factors
central lesions
cerebral central
cerebral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85593/98A
Inventor
Shinseiro Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Medicine Research Institute
Original Assignee
Advanced Medicine Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medicine Research Institute filed Critical Advanced Medicine Research Institute
Publication of AU8559398A publication Critical patent/AU8559398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU85593/98A 1998-08-05 1998-08-05 Remedies for cerebral central lesions with the use of neurotrophic factors Abandoned AU8559398A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1998/003478 WO2000007613A1 (en) 1998-08-05 1998-08-05 Remedies for cerebral central lesions with the use of neurotrophic factors

Publications (1)

Publication Number Publication Date
AU8559398A true AU8559398A (en) 2000-02-28

Family

ID=14208739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85593/98A Abandoned AU8559398A (en) 1998-08-05 1998-08-05 Remedies for cerebral central lesions with the use of neurotrophic factors

Country Status (2)

Country Link
AU (1) AU8559398A (en)
WO (1) WO2000007613A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1305294B1 (en) 1999-01-29 2001-05-04 Alessandro Lambiase USE OF THE NERVE GROWTH FACTOR IN THE THERAPY OF PATHOLOGIES DEPENDING ON INTRAOCULAR TISSUES.
US20030124095A1 (en) * 2001-12-31 2003-07-03 Regents Of The University Of California Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
ITRM20050447A1 (en) * 2005-08-19 2007-02-20 Anabasis S R L USE OF THE NERVE GROWTH FACTOR IN COLLIRIUM IN THE PATHOLOGY OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0418034A (en) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd Eye drop composition
JPH0474135A (en) * 1990-07-13 1992-03-09 Kanegafuchi Chem Ind Co Ltd Eye drop composition
JPH07509600A (en) * 1992-06-12 1995-10-26 リジェネロン　ファーマシューティカルズ，インコーポレーテッド Treatment and diagnostic methods based on neurotrophin-4 expression
US5898066A (en) * 1994-08-26 1999-04-27 Children's Medical Center Corporation Trophic factors for central nervous system regeneration
JPH10218787A (en) * 1997-02-06 1998-08-18 Akio Okamoto Ophthalmic composition based on neurotrophic factor

Also Published As

Publication number Publication date
WO2000007613A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
AU1715000A (en) Thermography catheter
AU2876499A (en) Multi-zone support
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU3763299A (en) Supramolecular structures and process for making the same
AU5341799A (en) Topical anionic salicylate for disorders of the skin
AU2035401A (en) Lubricant combination and process for the preparation thereof
AU2653599A (en) Human cystatin f
AU5651799A (en) Remedies for photochemotherapy
AU5056099A (en) Compounds for use in the treatment of inflammation
AU6253399A (en) Dual use dispensing system
AU4127597A (en) Biochemical markers of the human endometrium
AU1142600A (en) Catheter
AU2642699A (en) Remedies for brain infarction
AU8559398A (en) Remedies for cerebral central lesions with the use of neurotrophic factors
ZA97872B (en) Use of pyrolidine derivatives for the manufacture of medicaments.
AU4729397A (en) Agent for acting upon the organism
AU3936797A (en) De-icing agent
AU4416500A (en) Tomographic system
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU2967899A (en) Urinary catheter with locking
ZA995212B (en) The use of aryl-cyclohexylamine derivatives against CNS disorders.
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU1594397A (en) Use of colostrum for the treatment of constipation
AU1821900A (en) Process for the preparation of quinazolinones
AU4453301A (en) Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase